Impact of cannabidiol on the acute memory and psychotomimetic effects of smoked cannabis: naturalistic study: naturalistic study [corrected]
- PMID: 20884951
- DOI: 10.1192/bjp.bp.110.077503
Impact of cannabidiol on the acute memory and psychotomimetic effects of smoked cannabis: naturalistic study: naturalistic study [corrected]
Erratum in
- Br J Psychiatry. 2010 Nov;197:416
Abstract
Background: The two main constituents of cannabis, cannabidiol and Δ(9)-tetrahydrocannabinol (THC), have opposing effects both pharmacologically and behaviourally when administered in the laboratory. Street cannabis is known to contain varying levels of each cannabinoid.
Aims: To study how the varying levels of cannabidiol and THC have an impact on the acute effects of the drug in naturalistic settings.
Method: Cannabis users (n = 134) were tested 7 days apart on measures of memory and psychotomimetic symptoms, once while they were drug free and once while acutely intoxicated by their own chosen smoked cannabis. Using an unprecedented methodology, a sample of cannabis (as well as saliva) was collected from each user and analysed for levels of cannabinoids. On the basis of highest and lowest cannabidiol content of cannabis, two groups of individuals were directly compared.
Results: Groups did not differ in the THC content of the cannabis they smoked. Unlike the marked impairment in prose recall of individuals who smoked cannabis low in cannabidiol, participants smoking cannabis high in cannabidiol showed no memory impairment. Cannabidiol content did not affect psychotomimetic symptoms, which were elevated in both groups when intoxicated.
Conclusions: The antagonistic effects of cannabidiol at the CB(1) receptor are probably responsible for its profile in smoked cannabis, attenuating the memory-impairing effects of THC. In terms of harm reduction, users should be made aware of the higher risk of memory impairment associated with smoking low-cannabidiol strains of cannabis like 'skunk' and encouraged to use strains containing higher levels of cannabidiol.
Comment in
-
Does cannabidiol protect against the negative effects of THC?Br J Psychiatry. 2010 Oct;197(4):259-60. doi: 10.1192/bjp.bp.110.081380. Br J Psychiatry. 2010. PMID: 20884945
Similar articles
-
Sub-chronic impact of cannabinoids in street cannabis on cognition, psychotic-like symptoms and psychological well-being.Psychol Med. 2012 Feb;42(2):391-400. doi: 10.1017/S0033291711001322. Epub 2011 Jul 29. Psychol Med. 2012. PMID: 21798112
-
Cannabidiol attenuates the appetitive effects of Delta 9-tetrahydrocannabinol in humans smoking their chosen cannabis.Neuropsychopharmacology. 2010 Aug;35(9):1879-85. doi: 10.1038/npp.2010.58. Epub 2010 Apr 28. Neuropsychopharmacology. 2010. PMID: 20428110 Free PMC article. Clinical Trial.
-
Individual and combined effects of acute delta-9-tetrahydrocannabinol and cannabidiol on psychotomimetic symptoms and memory function.Transl Psychiatry. 2018 Sep 5;8(1):181. doi: 10.1038/s41398-018-0191-x. Transl Psychiatry. 2018. PMID: 30185793 Free PMC article. Clinical Trial.
-
Current Cannabidiol Safety: A Review.Curr Drug Saf. 2023;18(4):465-473. doi: 10.2174/1574886317666220902100511. Curr Drug Saf. 2023. PMID: 36056846 Review.
-
Actions of delta-9-tetrahydrocannabinol in cannabis: relation to use, abuse, dependence.Int Rev Psychiatry. 2009 Apr;21(2):104-12. doi: 10.1080/09540260902782752. Int Rev Psychiatry. 2009. PMID: 19367504 Free PMC article. Review.
Cited by
-
Does acute cannabidiol (CBD) use impair performance? A meta-analysis and comparison with placebo and delta-9-tetrahydrocannabinol (THC).Neuropsychopharmacology. 2024 Aug;49(9):1425-1436. doi: 10.1038/s41386-024-01847-w. Epub 2024 Mar 25. Neuropsychopharmacology. 2024. PMID: 38528133 Free PMC article.
-
Δ9-Tetrahydrocannabinol does not upregulate an aversive dopamine receptor mechanism in adolescent brain unlike in adults.Curr Res Neurobiol. 2023 Sep 4;5:100107. doi: 10.1016/j.crneur.2023.100107. eCollection 2023. Curr Res Neurobiol. 2023. PMID: 38020805 Free PMC article.
-
Decoding the Postulated Entourage Effect of Medicinal Cannabis: What It Is and What It Isn't.Biomedicines. 2023 Aug 21;11(8):2323. doi: 10.3390/biomedicines11082323. Biomedicines. 2023. PMID: 37626819 Free PMC article. Review.
-
Should oncologists trust cannabinoids?Front Pharmacol. 2023 Jul 13;14:1211506. doi: 10.3389/fphar.2023.1211506. eCollection 2023. Front Pharmacol. 2023. PMID: 37521486 Free PMC article. Review.
-
Assessing Cannabis Use Disorder in Medical Cannabis Patients: Interim Analyses from an Observational, Longitudinal Study.Cannabis. 2021 Oct 1;4(2):47-59. doi: 10.26828/cannabis/2021.02.004. eCollection 2021. Cannabis. 2021. PMID: 37287530 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical